Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Diagnosing Skin Disease in Patients with Dark Skin

Thomas R. Collins  |  November 23, 2024

“If you’re not routinely checking this, please check this antibody; it’s so important,” she said.

With limited scleroderma, patients often have Raynaud’s syndrome for years before other symptoms or recognition of disease, and skin thickening is usually limited to the fingers. These patients do not need treatment directed at the skin.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We really need to avoid immunosuppression in most of these patients,” Dr. Hummers said.

Scleredema almost always starts at the back of the neck, on the upper back and around the shoulders, possibly progressing to the chest, back and upper arms. It feels what Dr. Hummers called “doughy” when you pinch it.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s clear thick, but it feels doughier than scleroderma does,” she said. It most often occurs in the setting of poorly controlled Type 2 diabetes.

Eosinophilic fasciitis has a distribution in the extremities and the trunk but usually spares the hands and feet. Its skin quality is “woody” and deep, Dr. Hummers said.

“You should be able to pinch the skin but it feels thick under, so you can almost push the skin over this thickened fascia,” she said.

Peripheral eosinophilia can be found sometimes, but she cautioned this will disappear even with a bit of steroid treatment, so its absence doesn’t rule out eosinophilic fasciitis.

“If you see somebody who you know has morphea, you should really also kind of feel for eosinophilic fasciitis changes,” she said, because this may trigger treatment with corticosteroids. She also said there have been many reports of eosinophilic fasciitis after the use of checkpoint inhibitors.


Thomas R. Collins is a freelance medical writer based in Florida.

References

  1. Shen Z, Shao J, Sun J, Xu J. Exosomes released by melanocytes modulate fibroblasts to promote keloid formation: A pilot study. J Zhejiang Univ Sci B. 2022 Aug 15;23(8):699–704.
  2. Morgan N, Hummers LK. Scleroderma mimickers. Curr Treatm Op Rheumatol. 2016 Mar; 2(1): 69–84.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsPsoriatic ArthritisSystemic Sclerosis Tagged with:ACR Convergence 2024

Related Articles

    A Case of Eosinophilic Fasciitis Presenting with Pansclerotic Morphea

    May 17, 2019

    Eosinophilic fasciitis generally presents with the acute onset of edema followed by progressive skin induration in the setting of hypergammaglobulinemia, an elevated erythrocyte sedimentation rate (ESR) and peripheral eosinophilia in 63–93% of patients.1,2 Skin involvement is typically limited to 20.1% of total body surface area and most commonly involves the extremities symmetrically.1,3 The condition was…

    Kamolrat/SHUTTERSTOCK.COM

    Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists

    June 15, 2015

    Clinical Vignette A 45-year-old woman with long-standing asthma and chronic sinusitis has new-onset peripheral neuropathy, arthralgias, fatigue, progressive dyspnea and a nonproductive cough. She has never smoked and has no environmental exposures. Her medications include an albuterol metered-dose inhaler (which she uses daily); an inhaled corticosteroid, montelukast; and ibuprofen (which she takes occasionally). She is…

    Fibrotic Diseases of the Retroperitoneum & Skin, & Rare Scleroderma Mimics

    January 19, 2018

    SAN DIEGO—Fibrosis affects all organ systems, but isn’t always systemic sclerosis. Experts on less common forms discussed patient presentations, diagnosis and treatment at the 2017 ACR/ARHP Annual Meeting in San Diego on Nov. 6. Retroperitoneal Fibrosis Formerly called Ormond’s disease, retroperitoneal fibrosis (RPF) is usually an IgG4-related disease, but has some unique characteristics, said John…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences